China Life Insurance Company Limited (2628.HK) saw its stock soar by 5.02% in Friday's pre-market trading, following the release of its impressive 2025 interim financial results. The country's largest life insurer reported significant growth across key metrics, demonstrating successful business transformation and strong market performance.

According to the interim report released on August 27th, China Life achieved a net profit attributable to shareholders of 40.931 billion yuan in the first half of 2025, representing a 6.9% year-on-year increase. Total premiums reached a historical high of 525.088 billion yuan, growing 7.3% compared to the same period last year. Notably, the company's new business value surged by 20.3% year-on-year to 28.546 billion yuan, indicating improved profitability of its insurance products.

The strong performance can be attributed to China Life's strategic focus and transformational changes. The company reported significant progress in its business structure transformation, with floating return products' share in first-year regular premiums increasing by over 45 percentage points compared to the previous year. Additionally, China Life's investment portfolio showed robust growth, with total investment assets reaching 7.127 trillion yuan, up 7.8% from the end of 2024. The company achieved a net investment yield of 2.78% and a total investment yield of 3.29% in the first half of 2025. Looking ahead, China Life remains optimistic about the A-share market and plans to focus on new productive forces and high-quality, high-dividend stocks in its equity allocation strategy. The positive results and future outlook have likely contributed to investor confidence, driving the stock's significant price increase.